| dc.contributor.author | Smith, Katharine A | |
| dc.contributor.author | Freeman, Daniel | |
| dc.contributor.author | Cipriani, Andrea | |
| dc.date.accessioned | 2021-06-18T15:14:14Z | |
| dc.date.available | 2021-06-18T15:14:14Z | |
| dc.date.issued | 2021-04 | |
| dc.identifier.citation | Katharine Smith, Sinéad Lambe, Daniel Freeman, Andrea Cipriani. COVID-19 vaccines, hesitancy and mental health. Based Mental Health: first published as 10.1136/ebmental-2021-300266 on 13 April 2021 | en |
| dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/838 | |
| dc.description.abstract | ‘None of us will be safe until everyone is
safe. Global access to coronavirus vaccines,
tests and treatments for everyone who
needs them, anywhere, is the only way
out’. This statement by Dr Tedros
Adhanom Ghebreyesus, Director-General
of the WHO and Ursula von der Leyen,
President of the European Commission1
has become the rallying call for COVID-19
vaccination. The success of a safe and efficacious COVID-19 vaccine depends just
not only on production and availability
but also crucially on uptake. | en |
| dc.description.sponsorship | Supported by the NIHR | en |
| dc.description.uri | https://doi:10.1136/ebmental-2021-300266 | en |
| dc.language.iso | en | en |
| dc.subject | COVID-19 | en |
| dc.subject | Vaccine Hesitancy | en |
| dc.title | COVID-19 vaccines, hesitancy and mental health | en |
| dc.type | Article | en |